Get the Stockscreener App
1.00
2.30%
0.0225
After Hours:
1.02
0.02
+2.00%
Assertio Holdings Inc stock is traded at $1.00, with a volume of 1.33M.
It is up +2.30% in the last 24 hours and down -9.09% over the past month.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
See More
Previous Close:
$0.9775
Open:
$0.99
24h Volume:
1.33M
Relative Volume:
2.18
Market Cap:
$95.48M
Revenue:
$169.43M
Net Income/Loss:
$-186.01M
P/E Ratio:
0.6757
EPS:
1.48
Net Cash Flow:
$70.07M
1W Performance:
+6.29%
1M Performance:
-9.09%
6M Performance:
+5.04%
1Y Performance:
-7.83%
1-Day Range:
$0.9722
$1.0399
1-Week Range:
$0.943
$1.05
52-Week Range:
$0.7324
$1.798
Assertio Holdings Inc Stock (ASRT) Company Profile
Name
Assertio Holdings Inc
Sector
Phone
(224) 419-7106
Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Compare ASRT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
1.00 | 95.48M | 169.43M | -186.01M | 70.07M | -2.02 |
|
ZTS
Zoetis Inc
|
175.25 | 79.07B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.66 | 43.68B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.62 | 43.18B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.01B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
13.09 | 15.62B | 15.05B | -883.30M | 1.89B | -0.74 |
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-26-24 | Initiated | Maxim Group | Buy |
| Jul-03-24 | Initiated | H.C. Wainwright | Buy |
| Nov-07-22 | Initiated | Lake Street | Buy |
| Nov-30-18 | Downgrade | Mizuho | Buy → Neutral |
Assertio Holdings Inc Stock (ASRT) Latest News
HC Wainwright Forecasts Stronger Earnings for Assertio - MarketBeat
Assertio shares hold price target, buy rating on stable Indocin share By Investing.com - Investing.com Canada
Assertio (NASDAQ:ASRT) Receives Buy Rating from HC Wainwright - MarketBeat
Assertio Holdings Q3 2024 Earnings Preview - MSN
Assertio stock gains amid Q3 earnings, clash with activist investor - MSN
Insider Buying: Assertio Holdings, Inc. (NASDAQ:ASRT) Director Acquires $60,000.00 in Stock - MarketBeat
Assertio Holdings director Heather Mason buys $60,000 in shares By Investing.com - Investing.com Nigeria
Assertio Holdings director Heather Mason buys $60,000 in shares - Investing.com
Assertio Holdings CEO Brendan O'Grady buys $9,950 in common stock - Investing.com India
Spectrum Pharma Faces Senate Probe Call Over Alleged Rolvedon Data Fraud | ASRT Stock News - StockTitan
Assertio Holdings Inc (ASRT) Quarterly 10-Q Report - Quartzy
Assertio Holdings Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2024 Earnings Call Transcript - Insider Monkey
Assertio Reports Third Quarter 2024 Financial Results - The Manila Times
Assertio: Q3 Earnings Snapshot - The Washington Post
Assertio Therapeutics’ Q3 2024 Earnings Overview - TipRanks
Assertio stock gains amid Q3 earnings, clash with activist investor (NASDAQ:ASRT) - Seeking Alpha
Assertio (ASRT) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Assertio Holdings, Inc. Announces Board Changes - Marketscreener.com
Assertio Holdings Faces SEC Whistleblower Complaint Over Alleged Clinical Data Fraud | ASRT Stock News - StockTitan
Assertio Provides Response to Letter from Short-seller - GlobeNewswire
Assertio Holdings CEO Fires Back at Short-Seller's 'Baseless' Rolvedon Claims | ASRT Stock News - StockTitan
Assertio Holdings (NASDAQ:ASRT investor five-year losses grow to 72% as the stock sheds US$17m this past week - Simply Wall St
Assertio faces fraud claims, investor goes short on stock By Investing.com - Investing.com India
Assertio Stock Alert: Major Investor Warns of Fraud Claims, Safety Issues in Spectrum Deal | ASRT Stock News - StockTitan
Assertio Holdings Inc (ASRT) Q3 2024: Everything You Need to Know Ahead of Earnings - Yahoo Finance
Sidoti Csr Issues Negative Forecast for Assertio Earnings - MarketBeat
Assertio (ASRT) Scheduled to Post Earnings on Monday - MarketBeat
ASRTAssertio Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024 - The Manila Times
Non-Steroidal Anti-Inflammatory Drugs Market Sees Robust Growth Amid Rising Demand | PLC, and Assertio - EIN News
Director Vacirca Jeff L acquire 10,000 shares of Assertio Holdings Inc [ASRT] - Knox Daily
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024 - GlobeNewswire
A closer look at Assertio Holdings Inc (ASRT)’s stock price trends - US Post News
Assertio Holdings, Inc. (NASDAQ:ASRT) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
AQR Capital Management LLC Decreases Stock Holdings in Assertio Holdings, Inc. (NASDAQ:ASRT) - MarketBeat
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
ASRT Stock Sees Decline of Approximately -5.08% in Last Five Days - Knox Daily
Trading Day Triumph: Assertio Holdings Inc (ASRT) Ends at 1.12, a -2.61 Surge/Plunge - The Dwinnex
Assertio Holdings Inc Inc. (ASRT) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
ASOS PLC Reports Major Stake Acquired by SIH PARTNERS - TipRanks
Assertio Holdings Inc (ASRT) requires closer examination - US Post News
Metric Deep Dive: Understanding Assertio Holdings Inc (ASRT) Through its Ratios - The Dwinnex
Is Assertio Holdings (NASDAQ:ASRT) Using Debt Sensibly? - Simply Wall St
ASTRAZENECA PHARMA Share Price Today Down 5% - Equitymaster
Insider Selling: Asana, Inc. (NYSE:ASAN) COO Sells 29,807 Shares of Stock - Defense World
Manuel Alba Sells 37,000 Shares of Astera Labs, Inc. (NASDAQ:ALAB) Stock - Defense World
Astera Labs director sells over $5 million in company stock By Investing.com - Investing.com Canada
Magnetar Financial LLC Buys Shares of 20,305 Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
Views of Wall Street’s Leading Experts on Astera Labs Inc. - SETE News
Assertio Holdings Inc Stock (ASRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):